OncoLinea Pharmaceuticals
- Headquarters
- Menlo Park, California
- Employees
- 1–10
- Business Model
- B2B
- Last Round
- Venture Round
- Rounds
- 1
About
OncoLinea Pharmaceuticals is a biopharmaceutical company created by Canaan Partners focused on novel mechanisms to treat cancer, including DNA repair inhibitors targeting the LINE-1 retrotransposon pathway. Co-founded by cancer genomics researchers, the company has operated in stealth mode with no public product details disclosed, and several academic conflict-of-interest disclosures link it to 'Oncolinea/PrimeFour Therapeutics.'
Summary
OncoLinea Pharmaceuticals is a Biotech company based in Menlo Park, United States. Investors include Canaan Partners.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oncolinea-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/oncolinea-pharmaceuticals" alt="OncoLinea Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>